Abstract
Being the most common malignancy affecting patient's lifetime worldwide, the diagnosis of breast cancer especially in its early stages is of paramount importance (Wang, 2017). It has been reported that about 22.6 in 100,000 Iranian women would develop the primary breast cancer during their lifetime (Jazayeri et al., 2015). As a heterogeneous disease, which could be influenced through genetic or epigenetic mechanisms as well as environmental risk factors, characterization and treatment of breast cancer could be extremely demanding (Chen et al., 2011; Turnbull et al., 2011; Byler et al., 2014). Therefore, recent studies have been emphasizing on finding the potential risk factors contributing to the development, progression and response to the therapy of the disease (Ambrosone et al., 2015).
| Original language | English |
|---|---|
| Article number | 104514 |
| Number of pages | 8 |
| Journal | Experimental and molecular pathology |
| Volume | 116 |
| Early online date | 29 Jul 2020 |
| DOIs | |
| Publication status | Published - 31 Oct 2020 |
Bibliographical note
Acknowledgements:The authors thank all participants in this research. We would also like to thank the Student Research Committee, Mashhad University of Medical Sciences and Omid hospital (Mashhhad, Iran) to support the project.
Funding:
This work was financially supported by Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran, under Grant 961686.
